Monotherapy vs Combination Therapy for Bone Infections Caused by Pseudomonas Aeruginosa
Recruiting now
Conditions studied: Osteomyelitis, Pseudomonas Infections, Pseudomonas Aeruginosa, Bacterial Infections
In brief
This study looks at how well one antibiotic (monotherapy) works compared to two antibiotics (combination therapy) in treating bone infections caused by Pseudomonas aeruginosa. It includes 300 adult patients who had this type of infection confirmed by lab tests and medical imaging. The goal is to find out if using just one antibiotic is as effective as using two, while also looking at side effects, the need for more surgery, antibiotic resistance, and overall antibiotic use.
Key facts
- Study ID
- NCT07056881
- Run by
- Centre Hospitalier de Saint-Denis
- People needed
- 300
- Starts
- 2025-04-11
- Expected to finish
- 2026-04-15
- Last updated by the study team
- 2025-07-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients (≥18 years old)
- Diagnosis of osteitis or osteomyelitis due to Pseudomonas aeruginosa
- Isolation of Pseudomonas aeruginosa from at least one deep, sterile sample (e.g., bone biopsy, joint aspiration)
- Imaging findings consistent with osteomyelitis (MRI, CT scan, or X-ray)
You may not qualify if…
- No isolation of Pseudomonas aeruginosa
- No imaging evidence suggestive of osteomyelitis
- Patients under 18 years of age
Where it is running
- Centre Hospitalier de Saint-Denis — Saint-Denis, France, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.